{"transactions":[{"id":1602494,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T11:23:17.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the one year period beginning February 29, 2024."}],"balance_after":35000,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001516551-24-000025","document":"wk-form4_1709551390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655124000025/wk-form4_1709551390.xml","form_type":"4"}},{"id":1748439,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-07T01:32:26.000Z","date":"2023-11-06","kind":"grant","planned":false,"acquired":true,"shares":14110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $3.50 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023."}],"balance_after":20001,"derivative":{"exercise_price":3.5,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":14110},"source":{"system":"sec-edgar","filing":"0001516551-23-000098","document":"wk-form4_1699320737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000098/wk-form4_1699320737.xml","form_type":"4"}},{"id":1793933,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-29T22:17:30.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":1472692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $0.014 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the one year period beginning August 24, 2023."}],"balance_after":1472692,"derivative":{"exercise_price":0.014,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":1472692},"source":{"system":"sec-edgar","filing":"0001516551-23-000056","document":"wk-form4_1693347437.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000056/wk-form4_1693347437.xml","form_type":"4"}},{"id":2058494,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T15:42:39.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 and the options will vest in equal monthly installments over the one year period beginning December 8, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.017,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001516551-23-000010","document":"wf-form4_167327894567784.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000010/wf-form4_167327894567784.xml","form_type":"4"}},{"id":2469549,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Option Grant (Right to Buy)","published_at":"2021-12-16T23:50:43.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option grant shall be exercisable for a price of $0.058 per Option Share for ten years from December 14, 2021 (the \"Grant Date\") and the Options will vest in equal monthly installments over the one year period from the Grant Date."}],"balance_after":250000,"derivative":{"exercise_price":0.058,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001516551-21-000025","document":"wf-form4_163969862196316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655121000025/wf-form4_163969862196316.xml","form_type":"4"}},{"id":3628614,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":25184,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":25184},"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628613,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":8367,"price":11.62,"value":97224.54,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":25184,"derivative":{"underlying":"Class A common stock","underlying_shares":8367},"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628612,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":16817,"price":11,"value":184987.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":16817,"derivative":{"underlying":"Class A common stock","underlying_shares":16817},"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628611,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":8367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":8367},"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628610,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-26","kind":"exercise","acquired":false,"shares":16817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options, representing a right to purchase a total of 108,150 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":76150,"derivative":{"exercise_price":11,"expiration_date":"2026-05-25","underlying":"Class B common stock","underlying_shares":16817},"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628609,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-25","kind":"exercise","acquired":false,"shares":15183,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":15183},"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628608,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-25","kind":"exercise","acquired":true,"shares":15183,"price":11,"value":167013.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":15183,"derivative":{"underlying":"Class A common stock","underlying_shares":15183},"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628607,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-25","kind":"exercise","acquired":false,"shares":15183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options, representing a right to purchase a total of 108,150 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":92967,"derivative":{"exercise_price":11,"expiration_date":"2026-05-25","underlying":"Class B common stock","underlying_shares":15183},"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628606,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":8367,"price":91.62,"value":766584.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."}],"balance_after":8620,"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628605,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":16817,"price":91,"value":1530347.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."}],"balance_after":16987,"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628604,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-26","kind":"exercise","acquired":true,"shares":25184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":33804,"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628603,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":15183,"price":91,"value":1381653.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."}],"balance_after":8620,"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3628602,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-02-27T16:22:33.000Z","date":"2019-02-25","kind":"exercise","acquired":true,"shares":15183,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":23803,"source":{"system":"sec-edgar","filing":"0001209191-19-014057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119014057/doc4.xml","form_type":"4"}},{"id":3679403,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-02-01T11:50:18.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":4150,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":4150},"source":{"system":"sec-edgar","filing":"0001209191-19-006341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/doc4.xml","form_type":"4"}},{"id":3679402,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-02-01T11:50:18.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":4150,"price":11.62,"value":48223.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4150,"derivative":{"underlying":"Class A common stock","underlying_shares":4150},"source":{"system":"sec-edgar","filing":"0001209191-19-006341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/doc4.xml","form_type":"4"}},{"id":3679401,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-01T11:50:18.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":4150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":8367,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":4150},"source":{"system":"sec-edgar","filing":"0001209191-19-006341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/doc4.xml","form_type":"4"}},{"id":3679400,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-02-01T11:50:18.000Z","date":"2019-01-31","kind":"sale","acquired":false,"shares":2750,"price":76.9678,"value":211661.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $76.73 to $77.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":8620,"source":{"system":"sec-edgar","filing":"0001209191-19-006341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/doc4.xml","form_type":"4"}},{"id":3679399,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-02-01T11:50:18.000Z","date":"2019-01-31","kind":"sale","acquired":false,"shares":1400,"price":76.1719,"value":106640.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $75.68 to $76.53. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":11370,"source":{"system":"sec-edgar","filing":"0001209191-19-006341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/doc4.xml","form_type":"4"}},{"id":3679398,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-02-01T11:50:18.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":4150,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":12770,"source":{"system":"sec-edgar","filing":"0001209191-19-006341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119006341/doc4.xml","form_type":"4"}},{"id":3695417,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-01-15T11:25:08.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":8620,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":8620},"source":{"system":"sec-edgar","filing":"0001209191-19-003672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119003672/doc4.xml","form_type":"4"}},{"id":3695416,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-01-15T11:25:08.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":8620,"price":11.62,"value":100164.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":8620,"derivative":{"underlying":"Class A common stock","underlying_shares":8620},"source":{"system":"sec-edgar","filing":"0001209191-19-003672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119003672/doc4.xml","form_type":"4"}},{"id":3695415,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-15T11:25:08.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":8620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":12517,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":8620},"source":{"system":"sec-edgar","filing":"0001209191-19-003672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119003672/doc4.xml","form_type":"4"}},{"id":3695414,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-01-15T11:25:08.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":8620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":8620,"source":{"system":"sec-edgar","filing":"0001209191-19-003672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119003672/doc4.xml","form_type":"4"}},{"id":3707821,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-01-03T14:45:07.000Z","date":"2019-01-02","kind":"exercise","acquired":false,"shares":4150,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":4150},"source":{"system":"sec-edgar","filing":"0001209191-19-000798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/doc4.xml","form_type":"4"}},{"id":3707820,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2019-01-03T14:45:07.000Z","date":"2019-01-02","kind":"exercise","acquired":true,"shares":4150,"price":11.62,"value":48223.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4150,"derivative":{"underlying":"Class A common stock","underlying_shares":4150},"source":{"system":"sec-edgar","filing":"0001209191-19-000798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/doc4.xml","form_type":"4"}},{"id":3707819,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-03T14:45:07.000Z","date":"2019-01-02","kind":"exercise","acquired":false,"shares":4150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":21137,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":4150},"source":{"system":"sec-edgar","filing":"0001209191-19-000798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/doc4.xml","form_type":"4"}},{"id":3707818,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-01-03T14:45:07.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":1320,"price":54.58,"value":72045.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $54.27 to $55.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-000798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/doc4.xml","form_type":"4"}},{"id":3707817,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-01-03T14:45:07.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":2830,"price":53.71,"value":151999.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $53.26 to $54.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":1320,"source":{"system":"sec-edgar","filing":"0001209191-19-000798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/doc4.xml","form_type":"4"}},{"id":3707816,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2019-01-03T14:45:07.000Z","date":"2019-01-02","kind":"exercise","acquired":true,"shares":4150,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4150,"source":{"system":"sec-edgar","filing":"0001209191-19-000798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119000798/doc4.xml","form_type":"4"}},{"id":3707815,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-03T14:37:56.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":34500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in sixteen equal quarterly installments beginning on April 2, 2019, subject to continued service through each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":34500,"derivative":{"exercise_price":55.73,"expiration_date":"2029-01-02","underlying":"Class B common stock","underlying_shares":34500},"source":{"system":"sec-edgar","filing":"0001209191-19-000786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919119000786/doc4.xml","form_type":"4"}},{"id":3770397,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-11-08T11:16:13.000Z","date":"2018-11-07","kind":"exercise","acquired":false,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-057707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/doc4.xml","form_type":"4"}},{"id":3770396,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-11-08T11:16:13.000Z","date":"2018-11-07","kind":"exercise","acquired":true,"shares":4750,"price":11.62,"value":55195.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4750,"derivative":{"underlying":"Class A common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-057707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/doc4.xml","form_type":"4"}},{"id":3770395,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-11-08T11:16:13.000Z","date":"2018-11-07","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":25287,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-057707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/doc4.xml","form_type":"4"}},{"id":3770394,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-11-08T11:16:13.000Z","date":"2018-11-07","kind":"sale","acquired":false,"shares":1053,"price":68.13,"value":71740.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $68.00 to $68.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-057707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/doc4.xml","form_type":"4"}},{"id":3770393,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-11-08T11:16:13.000Z","date":"2018-11-07","kind":"sale","acquired":false,"shares":3697,"price":66.64,"value":246368.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $66.62 to $67.32. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":1053,"source":{"system":"sec-edgar","filing":"0001209191-18-057707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/doc4.xml","form_type":"4"}},{"id":3770392,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-11-08T11:16:13.000Z","date":"2018-11-07","kind":"exercise","acquired":true,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001209191-18-057707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118057707/doc4.xml","form_type":"4"}},{"id":3777909,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-11-01T17:18:04.000Z","date":"2018-11-01","kind":"exercise","acquired":false,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-056805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056805/doc4.xml","form_type":"4"}},{"id":3777908,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-11-01T17:18:04.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":4750,"price":11.62,"value":55195.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4750,"derivative":{"underlying":"Class A common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-056805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056805/doc4.xml","form_type":"4"}},{"id":3777907,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-11-01T17:18:04.000Z","date":"2018-11-01","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013."}],"balance_after":30037,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-056805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056805/doc4.xml","form_type":"4"}},{"id":3777906,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-11-01T17:18:04.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":4750,"price":59.48,"value":282530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $59.34 to $59.71. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-056805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056805/doc4.xml","form_type":"4"}},{"id":3777905,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-11-01T17:18:04.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001209191-18-056805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056805/doc4.xml","form_type":"4"}},{"id":3783928,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-10-24T11:01:14.000Z","date":"2018-10-23","kind":"exercise","acquired":false,"shares":14250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001209191-18-056013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056013/doc4.xml","form_type":"4"}},{"id":3783927,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-10-24T11:01:14.000Z","date":"2018-10-23","kind":"exercise","acquired":true,"shares":14250,"price":11.62,"value":165585.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":14250,"derivative":{"underlying":"Class A common stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001209191-18-056013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056013/doc4.xml","form_type":"4"}},{"id":3783926,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-10-24T11:01:14.000Z","date":"2018-10-23","kind":"exercise","acquired":false,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":34787,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001209191-18-056013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056013/doc4.xml","form_type":"4"}},{"id":3783925,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-10-24T11:01:14.000Z","date":"2018-10-23","kind":"sale","acquired":false,"shares":14250,"price":57.08,"value":813390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on one day at prices ranging from $56.84 to $57.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-056013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056013/doc4.xml","form_type":"4"}},{"id":3783924,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-10-24T11:01:14.000Z","date":"2018-10-23","kind":"exercise","acquired":true,"shares":14250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":14250,"source":{"system":"sec-edgar","filing":"0001209191-18-056013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118056013/doc4.xml","form_type":"4"}},{"id":3870992,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-07-09T11:16:55.000Z","date":"2018-07-05","kind":"exercise","acquired":false,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-041949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118041949/doc4.xml","form_type":"4"}},{"id":3870991,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-07-09T11:16:55.000Z","date":"2018-07-05","kind":"exercise","acquired":true,"shares":4750,"price":11.62,"value":55195.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4750,"derivative":{"underlying":"Class A common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-041949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118041949/doc4.xml","form_type":"4"}},{"id":3870990,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-07-09T11:16:55.000Z","date":"2018-07-05","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":49037,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-18-041949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118041949/doc4.xml","form_type":"4"}},{"id":3870989,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-07-09T11:16:55.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":4750,"price":36.62,"value":173945.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-041949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118041949/doc4.xml","form_type":"4"}},{"id":3870988,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-07-09T11:16:55.000Z","date":"2018-07-05","kind":"exercise","acquired":true,"shares":4750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001209191-18-041949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118041949/doc4.xml","form_type":"4"}},{"id":3901308,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-06-07T11:37:37.000Z","date":"2018-06-05","kind":"exercise","acquired":false,"shares":28500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001209191-18-036228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118036228/doc4.xml","form_type":"4"}},{"id":3901307,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class B common stock","published_at":"2018-06-07T11:37:37.000Z","date":"2018-06-05","kind":"exercise","acquired":true,"shares":28500,"price":11.62,"value":331170.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":28500,"derivative":{"underlying":"Class A common stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001209191-18-036228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118036228/doc4.xml","form_type":"4"}},{"id":3901306,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-06-07T11:37:37.000Z","date":"2018-06-05","kind":"exercise","acquired":false,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 82,287 shares, vests in twenty equal quarterly installments beginning September 15, 2013, subject to continued service through each vesting date."}],"balance_after":53787,"derivative":{"exercise_price":11.62,"expiration_date":"2023-06-15","underlying":"Class B common stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001209191-18-036228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118036228/doc4.xml","form_type":"4"}},{"id":3901305,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-06-07T11:37:37.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":28500,"price":36.62,"value":1043670.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-036228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118036228/doc4.xml","form_type":"4"}},{"id":3901304,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Class A common stock","published_at":"2018-06-07T11:37:37.000Z","date":"2018-06-05","kind":"exercise","acquired":true,"shares":28500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":28500,"source":{"system":"sec-edgar","filing":"0001209191-18-036228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919118036228/doc4.xml","form_type":"4"}},{"id":4139003,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-12-07T16:10:50.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":84800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in sixteen equal quarterly installments beginning on March 6, 2018, subject to continued service through each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":84800,"derivative":{"exercise_price":24.75,"expiration_date":"2027-12-06","underlying":"Class B common stock","underlying_shares":84800},"source":{"system":"sec-edgar","filing":"0001209191-17-064410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919117064410/doc4.xml","form_type":"4"}},{"id":4528448,"issuer":{"id":12293,"kind":"organization","name":"REATA PHARMACEUTICALS INC","symbol":"RETA"},"owners":[{"id":93560,"kind":"person","name":"Ward Keith Wayne","position":1,"cik":"0001662394","reported_name":"Ward Keith Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-08T16:04:24.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in twenty equal quarterly installments beginning on March 7, 2017, subject to continued service through each vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date."}],"balance_after":85000,"derivative":{"exercise_price":22.57,"expiration_date":"2026-12-07","underlying":"Class B common stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-16-154136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1358762/000120919116154136/doc4.xml","form_type":"4"}}]}